Edwards Lifesciences (EW) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Edwards Lifesciences (EW) PT Lowered to $118 at Barclays on 3Q; 'Quarter Over Quarter Slowdown in U.S. TAVR Growth'
October 25, 2017 12:36 PM EDTBarclays lowered its price target on Edwards Lifesciences (NYSE: EW) to $118.00 (from $120.00) while maintaining a Equalweight rating, following the company's third quarter earnings report.
Analyst Matthew Taylor notes the company delivered third quarter earnings per share and revenue results below consensus projections, as... More
Edwards Lifesciences (EW) PT Lowered to $135 at Canaccord Genuity
October 25, 2017 5:33 AM EDTCanaccord Genuity lowered its price target on Edwards Lifesciences (NYSE: EW) to $135.00 (from $155.00) while maintaining a Buy rating.
Analyst Jason Mills remains positive on the stock noting LT TAVR & TMVR catalyst trump the negative NT trends and would be a buyer on weakness in the $100 range.
... More